{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:13:34Z","timestamp":1786734814000,"version":"build-2736575974"},"reference-count":27,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["01KL1911"],"award-info":[{"award-number":["01KL1911"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["I 4149-B"],"award-info":[{"award-number":["I 4149-B"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["297333"],"award-info":[{"award-number":["297333"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Hypertensive disorders of pregnancy (HDP) are associated with a high incidence of maternal and perinatal morbidity and mortality. HDP, in particular pre-eclampsia, have been determined as risk factors for future cardiovascular disease. Recently, the common hypothesis of pre-eclampsia being a placental disorder was challenged as numerous studies show evidence for short-term and long-term cardiovascular changes in pregnancies affected by HDP, suggesting a cardiovascular origin of the disease. Despite new insights into the pathophysiology of HDP, concepts of therapy remain unchanged and evidence for improved maternal and neonatal outcome by using antihypertensive agents is lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>A prospective observational case\u2013control study, including 100\u2009women with HDP and 100 healthy controls, which will assess maternal haemodynamics using the USCOM 1A Monitor and Arteriograph along with cardiovascular markers (soluble fms-like kinase 1\/placental-like growth factor, N-terminal pro-B type natriuretic peptide) in women with HDP under antihypertensive therapy, including a follow-up at 3\u2009months and 1\u2009year post partum, will be conducted over a 50-month period in Vienna. A prospective, longitudinal study of cardiovascular surrogate markers conducted in Oslo will serve as a comparative cohort for the Vienna cohort of haemodynamic parameters in pregnancy including a longer follow-up period of up to 3 years post partum. Each site will provide a dataset of a patient group and a control group and will be assessed for the outcome categories USCOM 1A measurements, Arteriograph measurements and Angiogenic marker measurements. To estimate the effect of antihypertensive therapy on outcome parameters, ORs with 95% CIs will be computed. Longitudinal changes of outcome parameters will be compared between normotensive and hypertensive pregnancies using mixed-effects models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>Ethical approval has been granted to all participating centres. Results will be published in international peer-reviewed journals and will be presented at national and international conferences.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2022-065444","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T14:35:50Z","timestamp":1685630150000},"page":"e065444","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Maternal haemodynamics in Hypertensive Disorders of Pregnancy under antihypertensive therapy (HyperDiP): study protocol for a prospective observational case\u2013control study"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2449-2575","authenticated-orcid":false,"given":"Pilar","family":"Palmrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Haase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryam","family":"Sugulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Kalafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"key":"2023073121201102000_13.6.e065444.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00070-7"},{"key":"2023073121201102000_13.6.e065444.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68397-9"},{"key":"2023073121201102000_13.6.e065444.3","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000170652.71414.16"},{"key":"2023073121201102000_13.6.e065444.4","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.130765"},{"key":"2023073121201102000_13.6.e065444.5","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.150078"},{"key":"2023073121201102000_13.6.e065444.6","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.176537"},{"key":"2023073121201102000_13.6.e065444.7","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.162321"},{"key":"2023073121201102000_13.6.e065444.8","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12068"},{"key":"2023073121201102000_13.6.e065444.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.003664"},{"key":"2023073121201102000_13.6.e065444.10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/uog.17428","article-title":"Impaired maternal hemodynamics in Morbidly obese women: a case-control study","volume":"50","author":"Vinayagam","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2023073121201102000_13.6.e065444.11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/uog.17379","article-title":"Screening for pre-Eclampsia in the first trimester: role of maternal hemodynamics and Bioimpedance in non-obese patients","volume":"50","author":"Gagliardi","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2023073121201102000_13.6.e065444.12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/HYPERTENSIONAHA.117.10606","article-title":"Should maternal hemodynamics guide antihypertensive therapy in Preeclampsia","volume":"71","author":"McLaughlin","year":"2018","journal-title":"Hypertension"},{"key":"2023073121201102000_13.6.e065444.13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.preghy.2022.03.006","article-title":"The effect of impedance Cardiography directed antihypertensive therapy on fetal growth restriction rates and perinatal mortality in women with chronic hypertension","volume":"28","author":"Cottrell","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"2023073121201102000_13.6.e065444.14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/AOG.0b013e318197c392","article-title":"Antihypertensive therapy and central hemodynamics in women with hypertensive disorders in pregnancy","volume":"113","author":"Khalil","year":"2009","journal-title":"Obstet Gynecol"},{"key":"2023073121201102000_13.6.e065444.15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/uog.17341","article-title":"Serial hemodynamic monitoring to guide treatment of maternal hypertension leads to reduction in severe hypertension","volume":"49","author":"Stott","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2023073121201102000_13.6.e065444.16","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/HYPERTENSIONAHA.120.16502","article-title":"Preventing recurrent Preeclampsia by tailored treatment of Nonphysiologic hemodynamic adjustments to pregnancy","volume":"77","author":"Mulder","year":"2021","journal-title":"Hypertension"},{"key":"2023073121201102000_13.6.e065444.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414838"},{"key":"2023073121201102000_13.6.e065444.18","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.185264"},{"key":"2023073121201102000_13.6.e065444.19","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/uog.19040","article-title":"Addition of N-terminal pro-B natriuretic peptide to soluble FMS-like tyrosine Kinase-1\/Placental growth factor ratio >\u200938 improves prediction of pre-Eclampsia requiring delivery within 1\u2009week: a longitudinal cohort study","volume":"51","author":"Sabri\u00e1","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2023073121201102000_13.6.e065444.20","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/HYPERTENSIONAHA.117.09256","article-title":"Angiogenic markers and cardiovascular indices in the prediction of hypertensive disorders of pregnancy","volume":"69","author":"Verlohren","year":"2017","journal-title":"Hypertension"},{"key":"2023073121201102000_13.6.e065444.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2021.09.008"},{"key":"2023073121201102000_13.6.e065444.22","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1055\/s-0035-1557924","article-title":"Diagnosis and treatment of hypertensive pregnancy disorders guideline of DGGG (S1-level, AWMF Registry No015\/018","volume":"75","author":"Stepan","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"2023073121201102000_13.6.e065444.23","doi-asserted-by":"publisher","DOI":"10.3758\/BRM.41.4.1149"},{"key":"2023073121201102000_13.6.e065444.24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.preghy.2020.04.008","article-title":"Functional and structural vascular biomarkers in women 1 year after a hypertensive disorder of pregnancy","volume":"21","author":"Moe","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"2023073121201102000_13.6.e065444.25","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.172387"},{"key":"2023073121201102000_13.6.e065444.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.09.002"},{"key":"2023073121201102000_13.6.e065444.27","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11191"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-065444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T04:21:38Z","timestamp":1690863698000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-065444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6,1]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1136\/bmjopen-2022-065444"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-065444","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}